Clinical Trial Update: Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Arterial Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy of Plasma Rich in Growth Factors (PRGF) for treating foot ulcers in diabetic patients with peripheral arterial disease; cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Peripheral Artery Disease

Drugs mentioned

• Plasma Rich in Growth Factors (PRGF)

Snippet

Sponsor: Biotechnology Institute IMASD | Conditions: Foot Ulcers, Diabetic | Phase 4 | Status: RECRUITING